Late-onset Alzheimer disease risk variants mark brain regulatory loci

Neurology: Genetics

Volumn 1, Issue 2, 2015, Pages

  Allen, Mariet ^a   Kachadoorian, Michaela ^a   Carrasquillo, Minerva M ^a   Karhade, Aditya ^a   Manly, Lester ^a   Burgess, Jeremy D ^a   Wang, Chen ^d   Serie, Daniel ^b   Wang, Xue ^b   Siuda, Joanna ^a,e   Zou, Fanggeng ^a   Chai, High Seng ^d   Younkin, Curtis ^a   Crook, Julia ^b   Medway, Christopher ^a   Nguyen, Thuy ^a   Ma, Li ^a   Malphrus, Kimberly ^a   Lincoln, Sarah ^a   Petersen, Ronald C ^c   Graff Radford, Neill R ^b   Asmann, Yan W ^b   Dickson, Dennis W ^a   Younkin, Steven G ^a   Ertekin Taner, Nilüfer ^a,b   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Medical University of Silesia ^*  (United States)

^d MAYO CLINIC   (United States)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C1QTNF4 PROTEIN; C20ORF43 PROTEIN; CASS4 PROTEIN; CR1 PROTEIN; FERMT2 PROTEIN; HLA DRB1 ANTIGEN; MEF2C PROTEIN; MTCH2 PROTEIN; PILRB PROTEIN; PROTEIN; RAPSN PROTEIN; SLC24A4 PROTEIN; UNCLASSIFIED DRUG; ZCWPW1 PROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL CORTEX;

EID: 84969943555     PISSN: None     EISSN: 23767839     Source Type: Journal    
DOI: 10.1212/NXG.0000000000000012     Document Type: Article

References (31)

1. Harold D, Abraham R, Hollingworth P, et al. Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088-1093.
2. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010;303:1832-1840.
3. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011;43:436-441.
4. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011;43:429-435.
5. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Metaanalysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452-1458.
6. Ertekin-Taner N, De Jager PL, Yu L, Bennett DA. Alternative approaches in gene discovery and characterization in Alzheimer's disease. Curr Genet Med Rep 2013;1:39-51.
7. Allen M, Zou F, Chai HS, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 2012;79:221-228.
8. Ling IF, Bhongsatiern J, Simpson JF, Fardo DW, Estus S. Genetics of clusterin isoform expression and Alzheimer's disease risk. PLoS One 2012;7:e33923.
9. Vasquez JB, Fardo DW, Estus S. ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status. Neurosci Lett 2013;556:58-62.
10. Chapuis J, Hansmannel F, Gistelinck M, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 2013;18: 1225-1234.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
12. Carrasquillo MM, Zou F, Pankratz VS, et al. Genetic variation in PCDH11X is associated with susceptibility to lateonset Alzheimer's disease. Nat Genet 2009;41:192-198.
13. Zou F, Chai HS, Younkin CS, et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 2012;8: e1002707.
14. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
15. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-1099.
16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
17. Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-2337.
18. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-1797.
19. Ramasamy A, Trabzuni D, Guelfi S, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014;17:1418-1428.
20. Zhang B, Gaiteri C, Bodea LG, et al. Integrated systems approach identifies genetic nodes and networks in lateonset Alzheimer's disease. Cell 2013;153:707-720.
21. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch Neurol 2010;67:961-964.
22. Jun G, Naj AC, Beecham GW, et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010;67:1473-1484.
23. Brouwers N, Van Cauwenberghe C, Engelborghs S, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry 2012;17:223-233.
24. Crehan H, Hardy J, Pocock J. Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis 2013;54: 139-149.
25. Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J. Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology 2012;217:244-250.
26. Keenan BT, Shulman JM, Chibnik LB, et al. A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline. Hum Mol Genet 2012;21:2377-2388.
27. AppersonML, Tian Y, Stamova B, et al. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. J Neuroimmunol 2013;257:90-96.
28. Wissemann WT, Hill-Burns EM, Zabetian CP, et al. Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet 2013;93:984-993.
29. Stranger BE, Forrest MS, Clark AG, et al. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005;1:e78.
30. Doss S, Schadt EE, Drake TA, Lusis AJ. Cis-acting expression quantitative trait loci in mice. Genome Res 2005;15: 681-691.
31. Holton P, Ryten M, Nalls M, et al. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk loci. Ann Hum Genet 2013;77:85-105.